Target
Beta-lactamase
Ligand
BDBM466968
Substrate
n/a
Meas. Tech.
Inhibition of Beta-Lactamase Enzymes
IC50
51.0±n/a nM
Citation
 Comita-Prevoir, JDurand-Reville, TFGauthier, LO''Donnell, JRomero, JTommasi, RVerheijen, JCWu, FWu, XZhang, J Beta-lactamase inhibitor compounds US Patent  US10800778 Publication Date 10/13/2020 
Target
Name:
Beta-lactamase
Synonyms:
Beta-lactamase | OXA-48 | Synonyms=blaOXA-48 | bla
Type:
PROTEIN
Mol. Mass.:
30363.94
Organism:
Klebsiella pneumoniae
Description:
ChEMBL_103606
Residue:
265
Sequence:
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP
  
Inhibitor
Name:
BDBM466968
Synonyms:
US10800778, Example 10 | {[(2S,5R)-2-carbamoyl-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl]oxy}acetic acid lithium salt
Type:
Small organic molecule
Emp. Form.:
C10H13N3O5
Mol. Mass.:
255.2273
SMILES:
CC1=C[C@@H]2CN([C@@H]1C(N)=O)C(=O)N2OCC(O)=O |r,t:1|
Structure:
Search PDB for entries with ligand similarity: